Antimicrobial Agent Abbreviations
Amp- Ampicilin, Amox/Clav- Amoxicillin/Clavulanate, Amp/Sulb-Ampicillin/Sulbactam, Amik- Amikacin, Aztre-Aztreonam, Cefaz- Cefazolin, Ceftaz-Ceftazidime, Cefep-Cefepime, Chloro-Chloramphenicol, Clinda-Clindamycin, Eryth-Erythromycin, Gent-Gentamicin, Imip-Imipenem, Levo-Levofloxacin,Linz-Linezolid, Mero-Meropenem, Nitro-Nitrofurantoin, Norflox- Norfloxacin, Naf-Nafcillin, Pen-Penicillin, Pip/Tazo-Pipercillin/Tazobactam, Tetra-Tetracycline, Tmp/Sxt- Trimethoprim/Sulfamethoxazole, Tobra-Tobramycin, Vanco-Vancomycin
PMC Outpatients, Jan-Dec 2007, Blood Isolates
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Aztre	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Pip (Pip/Tazo)	Tmp/Sxt	Mero
E. coli	11	64	nt	nt	100	100	100	91	91	100	91	91(100)	55	100
PMC Outpatients, Jan-Dec 2007, Non-Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Amp/Sulb or Amox/Clav	Cefaz	Clinda	Ery	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Vanco
S. aureus	608	5	46	46	76	31	99	46	98	76	95	100	100
Staphylococcus, coag neg	18	6	50	50	28*	28	83	50	nt	50	nt	100	100
Enterococcus sp	52	77	nt	nt	nt	20	nt	nt	nt	63	42	90	86
*CNS not tested for inducible clindamycin resistance, susceptibility may be higher
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Mero	Pip (Pip/Tazo)	Tmp/Sxt
E. cloacae	15	0	0	0	100	100	100	100	100	100	100	100(100)	100
E. coli	48	54	nt	85	94	93	92	96	100	83	100	68(90)	79
K. pneumoniae	18	0	94	100	100	100	100	100	100	100	100	0(100)	94
P. mirabilis	22	96	100	96	96	96	100	100	100	100	100	96(100)	96
P. aeruginosa	97	nt	nt	nt	89	93	72	89	83	73	93	92	nt
S, marcescens	10	0	0	0	100	100	100	100	100	80	100	100(100)	90
PMC Outpatients, Jan-Dec 2007, Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Amp/Sulb or Amox/Clav	Cefaz	Ery	Clinda	Gent	Naf	Tmp/Sxt	Levo	Nitro	Tetra	Linz	Vanco
S. aureus	67	8	66	66	48	54	100	66	100	60	99	88	100	100
Staphylococcus, coag neg	149	7	42	42	48	48**	95	42	nt	67	nt	nt	100	100
Enterococcus sp	258	95	nt	nt	21	nt	nt	nt	nt	83	93	24	95	96
**CNS not routinely tested for inducible clindamycin resistance, susceptibility may be higher
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Gent	Tobra	Levo	Norflox	Nitro	Pip (Pip/Tazo)	Tmp/Sxt	Tetra	Mero
C. koseri	43	0	100	100	100	98	100	100	100	88	nt	98	98	nt
C. freundii	20	0	0	0	75	90	95	95	95	95	nt	90	85	nt
Pantoea (Enterobacter) aerogenes	35	0	0	0	100	100	100	100	100	8	nt	97	97	nt
E. cloacae	29	0	0	0	83	90	86	83	83	28	nt	79	76	nt
E. coli	2062	62	84	93	99	94	95	88	88	97	nt	82	80	nt
K. pneumoniae	274	0	93	90	93	97	93	92	92	28	nt	89	85	nt
K. oxytoca	22	0	96	64	100	100	100	91	96	82	nt	96	100	nt
M. morganii	13	0	0	0	92	92	100	92	92	0	nt	92	62	nt
P. mirabilis	120	98	100	100	100	99	99	97	96	0	nt	98	0	nt
P. aeruginosa	48	nt	nt	nt	92	90	96	58	nt	nt	98	nt	nt	94